Identification of Lymphoma-Associated Antigens Using SEREX
Serological analysis of recombinant complementary deoxyribonucleic acid (cDNA) expression libraries (SEREX) is a powerful approach to identify immunogenic cancer-associated proteins using antibodies that are naturally present in the serum of cancer patients. This technique involves the screening of a relevant cDNA expression library with patient serum that has been cleaned to remove any antibodies that may recognize bacterial and/or viral proteins. Once antigens have been identified and their reactivity has been confirmed with a second round of screening, the gene encoding the protein can be sequenced and identified. Antigens can then be screened with a panel of allogenic sera from other patients and control individuals. This identifies disease-specific antigens, which may be useful diagnostic markers or, alternatively, targets for immunotherapy. This chapter describes the SEREX methodology in full.
- c-erbB-2 Immunohistochemistry in Paraffin Tumors
- One-Dimensional Genome Scanning-Detection of Genomic Changes in Ovarian Carcinoma
- Chromosome Microdissection for Detection of Subchromosomal Alterations by FISH
- Combined Adenoviral Transfer of Tumor Suppressor and Cell-Cycle Genes for Tumor-Cell Apoptosis
- The Epidemiology of Ovarian Cancer
- 7 In Vitro Methods for Evaluation of P450-Based Anticancer Gene Therapy
- Screening for miRNA Expression Changes Using Quantitative PCR (Q-PCR)
- Analyzing the Spindle Checkpoint in Yeast and Frogs
- 华人博士发明单个神经细胞及突触体内标识技术
- 细胞电融合的原理和方法